Clear Search
·
1 MIN READ

AMA statement on Medicare Part D data release

The AMA is committed to transparency and the availability of reliable information for patients to make informed decisions about their medical care.

Press Releases
·
2 MIN READ

Review financial data before it goes public in June

Physicians have 45 days to review and dispute reports regarding their financial interactions with manufacturers of drugs and medical devices reported under the Physician Payments Sunshine Act. Here’s what you need to know about the process before data is made available to the public in June.

Medicare & Medicaid
·
6 MIN READ

10 top issues that impacted physicians in 2014

A number of regulatory, public health and practice issues took center stage for the medical profession this year. See the 10 topics that made some of the biggest waves among the physician community in 2014—and learn how they played out.

Medicare & Medicaid
·
3 MIN READ

2014's top moments in medical education

The past year was jam-packed with major events in medical education. Take a look back at six news-making medical education topics.

ChangeMedEd Initiative
·
2 MIN READ

CME cleared from reporting under Sunshine Act

With the release of the 2015 Medicare Physician Fee Schedule final rule Oct. 31, the Centers for Medicare & Medicaid Services (CMS) made it official: funding for independent continuing medical education (CME) will not be subject to reporting under the Physician Payments Sunshine Act as initially proposed by the agency earlier this summer.

Medicare & Medicaid
·
3 MIN READ

How AMA has advocated for Sunshine Act implementation overhaul

As the Centers for Medicare & Medicaid Services (CMS) rolls out the online database of physicians’ financial interactions with manufacturers of drugs and medical devices, troubling questions remain about the accuracy of the data and the lack of context with which it is being presented.

Medicare & Medicaid
·
4 MIN READ

Physicians call for changes to Medicare payment policy proposals

New proposed rules from the Centers for Medicare & Medicaid Services (CMS) would impact many aspects of physician payment and federal regulatory programs, but many of these changes are not for the better. In a letter sent last week, the AMA urged the agency to make revisions to avoid negative effects on physicians and patients.

Medicare & Medicaid
·
3 MIN READ

Time running out to review Sunshine data—and it isn't very accurate

Less than two weeks remain for physicians to review and dispute data about their financial interactions with medical device and drug manufacturers before the information goes public Sept. 30.

Medicare & Medicaid
·
2 MIN READ

What new physicians need to know about navigating regulations

Preparing to comply is important because many federal programs can bring financial penalties or other serious consequences if not carefully followed. Here are some of the main things new physicians need to know.

Medicare & Medicaid